Welcome
Welcome to CT3N
CT3N's mission is to facilitate research in drug delivery and nanomedicine. We do this via our annual symposium, monthly seminar series, grants, and other activities that bring together our dozens of member faculty from Penn, CHOP, and surrounding institutions.
2026 CT3N Symposium
Details coming soon
Hold the date: December 2, 2026
Missed the 2025 CT3N Symposium?
View the recordings
Upcoming Events
CT3N Faculty Publication Highlights
Shuvaev et al., PNAS (2025)
Papp et al., Molec. Therapy (2025)
Faculty in the News
Novel plant-based approach to a better, cheaper GLP-1 delivery system (Henry Daniell)
Tuesday, March 3, 2026
Penn Medicine and CHOP launch first CRISPR-based platform to pinpoint drivers of AML in patient cells (Kathrin Bernt)
Thursday, February 26, 2026
Tumor-on-a-Chip Offers Insight into Cancer-Fighting Cells in Immunotherapy (Dan Huh)
Monday, October 27, 2025
Nanoparticle Blueprints Reveal Path to Smarter Medicines (Mike Mitchell)
Thursday, October 23, 2025
Future mRNA vaccines may prevent food and seasonal allergies (Drew Weissman)
Friday, September 26, 2025
Featured Faculty
Noor Momin, PhD, Assistant Professor, Department of Bioengineering, School of Engineering and Applied Science
Dr. Noor Momin is the Stephenson Foundation Term Assistant Professor of Innovation. She completed her Bachelor of Science degree in Biomedical Engineering at the University of Texas at Austin and earned her Ph.D. in Biological Engineering. As a graduate student, Dr. Momin engineered a localization strategy that improves the safety and effectiveness of cytokine therapies used for cancer treatment. This technology is being evaluated in both canine and human clinical trials. She went on to conduct postdoctoral training at Massachusetts General Hospital where she examined the role of leukocytes in arrhythmia. In January of 2024, Dr. Momin launched her independent research group at University of Pennsylvania in the Bioengineering Department and the Penn Center for Precision Engineering for Health. The Momin lab seeks to understand and modulate the immune response for targeted treatment of cardiovascular diseases.